Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects

• Nikolaos A. Patsopoulos,

  Affiliations Program in Translational NeuroPsychiatric Genomics, Institute for the Neurosciences, Department of Neurology, Brigham & Women's Hospital, Boston, Massachusetts, United States of America, Division of Genetics, Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America

  ⨯
• Lisa F. Barcellos,

  Affiliations Division of Epidemiology, Genetic Epidemiology and Genomics Laboratory, School of Public Health, University of California, Berkeley, Berkeley, California, United States of America, Kaiser Permanente Division of Research, Oakland, California, United States of America

  ⨯
• Rogier Q. Hintzen,

  Affiliation Department of Neurology, MS Centre ErasMS, Erasmus MC, Rotterdam, The Netherlands

  ⨯
• Catherine Schaefer,

  Affiliation Kaiser Permanente Division of Research, Oakland, California, United States of America

  ⨯
• Cornelia M. van Duijn,

  Affiliation Genetic Epidemiology Unit, Department of Epidemiology and Biostatistics and Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands

  ⨯
• Janelle A. Noble,

  Affiliation Children's Hospital Oakland Research Institute, Oakland, California, United States of America

  ⨯
• Towfique Raj,

  Affiliations Program in Translational NeuroPsychiatric Genomics, Institute for the Neurosciences, Department of Neurology, Brigham & Women's Hospital, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America

  ⨯
• IMSGC ,

  ¶Membership of IMSGC and ANZgene is provided in the Acknowledgments.

  ⨯
• ANZgene ,

  ¶Membership of IMSGC and ANZgene is provided in the Acknowledgments.

  ⨯
• Pierre-Antoine Gourraud,

  Affiliation Department of Neurology, University, of California at San Francisco, San Francisco, California, United States of America

  ⨯
• Barbara E. Stranger,

  Affiliations Section of Genetic Medicine, Department of Medicine, University of Chicago, Chicago, Illinois, United States of America, Institute for Genomics and Systems Biology, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Jorge Oksenberg,

  Affiliation Department of Neurology, University, of California at San Francisco, San Francisco, California, United States of America

  ⨯
• Tomas Olsson,

  Affiliation Department of Clinical Neuroscience CMM, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Bruce V. Taylor,

  Affiliation Menzies Research Institute Tasmania, University of Tasmania, Hobart, Australia

  ⨯
• Stephen Sawcer,

  Affiliation University of Cambridge, Department of Clinical Neuroscience, Addenbrooke's Hospital, Cambridge, United Kingdom

  ⨯
• David A. Hafler,

  Affiliations Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America, Department of Neurology and Department of Immunobiology, Yale University, School of Medicine, New Haven, Connecticut, United States of America

  ⨯
• Mary Carrington,

  Affiliations Cancer and Inflammation Program, Laboratory of Experimental Immunology, SAIC Frederick, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America, Ragon Institute of MGH, MIT, and Harvard, Charlestown, Massachusetts, United States of America

  ⨯
• Philip L. De Jager ,

  Contributed equally to this work with: Philip L. De Jager, Paul I. W. de Bakker

  * E-mail: pdejager@rics.bwh.harvard.edu (PLDJ); pdebakker@umcutrecht.nl (PIWdB)

  Affiliations Program in Translational NeuroPsychiatric Genomics, Institute for the Neurosciences, Department of Neurology, Brigham & Women's Hospital, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America

  ⨯
•  [ ... ],
• Paul I. W. de Bakker

  Contributed equally to this work with: Philip L. De Jager, Paul I. W. de Bakker

  * E-mail: pdejager@rics.bwh.harvard.edu (PLDJ); pdebakker@umcutrecht.nl (PIWdB)

  Affiliations Division of Genetics, Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America, Department of Medical Genetics, Division of Biomedical Genetics, University Medical Center, Utrecht, The Netherlands, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands

  ⨯
• [ view all ]
• [ view less ]